 |
 |
 |
|
DRV CONCENTRATIONS AND VIRAL LOAD IN CSF OF PATIENTS ON DRV/r 600/100 OR 800/100 mg ONCE DAILY, PLUS TWO NRTI
|
|
|
Reported by Jules Levin
15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, May 19-21, 2014, Washington, DC
Di Yacovo S1, Molto J2, Ferrer E1, Curran A3, Else L4, Clotet B2, Tiraboschi J1, Niubo J1, Barrera G1, Podzamczer D1.
1 Hospital Universitari de Bellvitge, 2 Germans Trias, 3 Vall d'Hebron, Barcelona, Spain, and 4 University of Liverpool, UK.
15th Intl Wrkshp Clinical Pharm HIV Therapy Reduced Darunavir Dose Is as Effective in Maintaining HIV Suppression as the Standard Dose in Virologically Suppressed HIV-Infected Patients. The DRV600 Study - (05/21/14)





|
|
|
 |
 |
|
|